NeVa™ Success in Switzerland!

NeVa™ Success in Switzerland!

Jaqueline Staeuble, CEO of Infotrace Medical was joined by Diane Tangun, Vesalio’s VP, Market Development in Switzerland FEB 11-13. Multiple Swiss stroke centers were visited to review clinical progress with NeVa. Technical discussions ensued with neuro-endovascular physicians regarding the Drop Zone Technique and their positive patient outcomes with NeVa. Vesalio is excited with the progress of our distributor partner …. a believer in our unique technology and investing to bring it to stroke patients in her home country.



#DoTheDropZone #NeVa1stPass #LeaveNoClotBehind #stroke #ischemicstroke #thrombosis #bloodclot #thrombectomy #clot #ischemicstroketreatment #endovascularprocedures #endovascularinterventions #neurotechnology #stentretriever #acuteischemicstroke


Vesalio_CircleLogo_White.png

About

Technology

Careers

  • White LinkedIn Icon
  • White Facebook Icon
  • White Twitter Icon

NeVa T, M1, M1-S and VS are CE-Marked

Caution - Investigational Device Limited by Federal Law

to Investigational Use.

150x132_graphic_logo_web.gif